TY - JOUR
T1 - Acute Nonspecific Mesenteric Lymphadenitis
T2 - More Than "no Need for Surgery"
AU - Helbling, Rossana
AU - Conficconi, Elisa
AU - Wyttenbach, Marina
AU - Benetti, Cecilia
AU - Simonetti, Giacomo D.
AU - Bianchetti, Mario G.
AU - Hamitaga, Flurim
AU - Lava, Sebastiano A.G.
AU - Fossali, Emilio F.
AU - Milani, Gregorio P.
PY - 2017
Y1 - 2017
N2 - Acute nonspecific, or primary, mesenteric lymphadenitis is a self-limiting inflammatory condition affecting the mesenteric lymph nodes, whose presentation mimics appendicitis or intussusception. It typically occurs in children, adolescents, and young adults. White blood count and C-reactive protein are of limited usefulness in distinguishing between patients with and without mesenteric lymphadenitis. Ultrasonography, the mainstay of diagnosis, discloses 3 or more mesenteric lymph nodes with a short-axis diameter of 8 mm or more without any identifiable underlying inflammatory process. Once the diagnosis is established, supportive care including hydration and pain medication is advised. Furthermore, it is crucial to reassure patients and families by explaining the condition and stating that affected patients recover completely without residuals within 2-4 weeks.
AB - Acute nonspecific, or primary, mesenteric lymphadenitis is a self-limiting inflammatory condition affecting the mesenteric lymph nodes, whose presentation mimics appendicitis or intussusception. It typically occurs in children, adolescents, and young adults. White blood count and C-reactive protein are of limited usefulness in distinguishing between patients with and without mesenteric lymphadenitis. Ultrasonography, the mainstay of diagnosis, discloses 3 or more mesenteric lymph nodes with a short-axis diameter of 8 mm or more without any identifiable underlying inflammatory process. Once the diagnosis is established, supportive care including hydration and pain medication is advised. Furthermore, it is crucial to reassure patients and families by explaining the condition and stating that affected patients recover completely without residuals within 2-4 weeks.
UR - http://www.scopus.com/inward/record.url?scp=85013249618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013249618&partnerID=8YFLogxK
U2 - 10.1155/2017/9784565
DO - 10.1155/2017/9784565
M3 - Review article
C2 - 28261620
AN - SCOPUS:85013249618
VL - 2017
JO - BioMed Research International
JF - BioMed Research International
SN - 2314-6133
M1 - 9784565
ER -